Soleno Therapeutics

$1.92
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) As of 1:25 PM EST today

Why Robinhood?

You can buy or sell SLNO and other stocks, options, and ETFs commission-free!

About SLNO

Soleno Therapeutics, Inc. engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. The company focuses on the treatment of metabolic and neurobehavioral disorder. It offers its lead candidate, Diazoxide Choline Controlled-Release (DCCR), an oral tablet for the treatment of Prader-Willi Syndrome (PWS). The company was founded on August 25, 1999 and is headquartered in Redwood City, CA. The listed name for SLNO is Soleno Therapeutics, Inc. Common Stock.

CEO
Anish Bhatnagar
Employees
25
Headquarters
Redwood City, California
Founded
1999
Market Cap
153.66M
Price-Earnings Ratio
Dividend Yield
Average Volume
196.29K
High Today
$1.93
Low Today
$1.90
Open Price
$1.91
Volume
77.87K
52 Week High
$4.39
52 Week Low
$1.30

Collections

SLNO Earnings

-$0.36
-$0.23
-$0.10
$0.03
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 4, After Hours

You May Also Like